{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T22:17:14Z","timestamp":1790201834368,"version":"4.1.0"},"reference-count":16,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1097\/mbc.0b013e32830b14ef","type":"journal-article","created":{"date-parts":[[2008,9,26]],"date-time":"2008-09-26T08:38:16Z","timestamp":1222418296000},"page":"689-692","source":"Crossref","is-referenced-by-count":32,"title":["Efficacy and safety of once daily low molecular weight heparin (tinzaparin sodium) in high risk pregnancy"],"prefix":"10.1097","volume":"19","author":[{"given":"Fionnuala","family":"N\u00ed \u00c1inle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Audris","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niamh","family":"Appleby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Regan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tayyaba","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Milner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann O","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210203","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1182\/blood-2005-02-0626","article-title":"Low-molecular-weight heparins for thromboprophylaxis and treatment of venous thromboembolism in pregnancy: a systematic review of safety and efficacy","volume":"106","author":"Greer","year":"2005","journal-title":"Blood"},{"key":"R2-13-20210203","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1056\/NEJM199709043371007","article-title":"Low-molecular-weight heparins","volume":"337","author":"Weitz","year":"1997","journal-title":"N Engl J Med"},{"key":"R3-13-20210203","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1055\/s-0037-1614550","article-title":"Safety of low-molecular-weight heparin in pregnancy: a systematic review","volume":"81","author":"Sanson","year":"1999","journal-title":"Thromb Haemost"},{"key":"R4-13-20210203","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1160\/TH06-10-0606","article-title":"The management of thrombosis in pregnancy: role of low-molecular-weight heparin","volume":"97","author":"Kher","year":"2007","journal-title":"Thromb Haemost"},{"key":"R5-13-20210203","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/00001721-199806000-00006","article-title":"A pharmacokinetic study of dalteparin (Fragmin) during late pregnancy","volume":"9","author":"Blomback","year":"1998","journal-title":"Blood Coagul Fibrinolysis"},{"key":"R6-13-20210203","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/S0002-9378(99)70091-8","article-title":"Changes in the pharmacokinetics of the low-molecular-weight heparin enoxaparin sodium during pregnancy","volume":"181","author":"Casele","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"R7-13-20210203","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/S0002-9378(03)00953-0","article-title":"Tinzaparin sodium for thrombosis treatment and prevention during pregnancy","volume":"190","author":"Smith","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"R8-13-20210203","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1046\/j.1365-2141.2003.04196.x","article-title":"Low-molecular-weight heparins: are they all the same?","volume":"121","author":"White","year":"2003","journal-title":"Br J Haematol"},{"key":"R9-13-20210203","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1055\/s-0038-1651070","article-title":"Effects of an enzymatically depolymerized heparin as compared with conventional heparin in healthy volunteers","volume":"57","author":"Matzsch","year":"1987","journal-title":"Thromb Haemost"},{"key":"R10-13-20210203","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJM199204093261502","article-title":"Subcutaneous low-molecular-weight heparin compared with continuous intravenous heparin in the treatment of proximal-vein thrombosis","volume":"326","author":"Hull","year":"1992","journal-title":"N Engl J Med"},{"key":"R11-13-20210203","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1111\/j.1365-2141.2004.05304.x","article-title":"Low molecular weight heparin in pregnancy: current issues","volume":"128","author":"Greer","year":"2005","journal-title":"Br J Haematol"},{"key":"R12-13-20210203","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1111\/j.1365-2141.2007.06826.x","article-title":"The management of antenatal venous thromboembolism in the UK and Ireland: a prospective multicentre observational survey","volume":"139","author":"Voke","year":"2007","journal-title":"Br J Haematol"},{"key":"R13-13-20210203","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1055\/s-0038-1655903","article-title":"Thromboprophylaxis with low molecular weight heparin (Fragmin) in high risk pregnancies","volume":"77","author":"Hunt","year":"1997","journal-title":"Thromb Haemost"},{"key":"R14-13-20210203","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1055\/s-0038-1650538","article-title":"Low molecular weight heparin as thromboprophylaxis in familial thrombophilia during the whole period of pregnancy","volume":"76","author":"Boda","year":"1996","journal-title":"Thromb Haemost"},{"key":"R15-13-20210203","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2141.2002.03522.x","article-title":"Tissue factor and tissue factor pathway inhibitor levels in unstable angina patients during short-term low-molecular-weight heparin administration","volume":"117","author":"Gori","year":"2002","journal-title":"Br J Haematol"},{"issue":"Suppl 1","key":"R16-13-20210203","first-page":"89","article-title":"Factor Xa inhibition: correlation between the plasma levels of anti-Xa activity and occurrence of thrombosis and haemorrhage","volume":"23","author":"Leizorovicz","year":"1993","journal-title":"Haemostasis"}],"container-title":["Blood Coagulation & Fibrinolysis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00001721-200810000-00013","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T17:11:27Z","timestamp":1786036287000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00001721-200810000-00013"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":16,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2008]]}},"URL":"https:\/\/doi.org\/10.1097\/mbc.0b013e32830b14ef","relation":{},"ISSN":["0957-5235"],"issn-type":[{"value":"0957-5235","type":"print"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}